Oculis' main value driver appears to be OCS-01, which targets a respectable $4B DME TAM with its non-invasive eye drops. See ...

There are new treatments to help patients with glaucoma, and they’re just in time. The disease is the second leading cause of ...

Fort Worth, Texas-based Alcon Laboratories has voluntarily recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, which are packaged in batches of 25.

A new report shows the benefit of wearing contact lenses for slowing myopia has a lasting effect -- good news since 50% of the world (5 billion people) will likely be nearsighted by 2050.

Perfluorohexyloctane and lotilaner ophthalmic solution, 2 ocular surface disease drugs, have changed the DED and DB treatment paradigms.